On Circadian Variation of Myocardial Reperfusion Injury
2012; Lippincott Williams & Wilkins; Volume: 110; Issue: 1 Linguagem: Inglês
10.1161/circresaha.111.260265
ISSN1524-4571
Autores Tópico(s)Photoreceptor and optogenetics research
ResumoHomeCirculation ResearchVol. 110, No. 1On Circadian Variation of Myocardial Reperfusion Injury Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBOn Circadian Variation of Myocardial Reperfusion Injury Eugene Braunwald Eugene BraunwaldEugene Braunwald From the TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital; Department of Medicine, Harvard Medical School, Boston, MA. Originally published6 Jan 2012https://doi.org/10.1161/CIRCRESAHA.111.260265Circulation Research. 2012;110:6–7See related article, pages 105–110In 1729, Jean Jacques d'Ortous de Marian, a French scientist, made the fascinating observation that plants that unfolded their leaves when exposed to sunlight (presumably to increase photosynthesis, a process that had not yet been discovered) continued to rhythmically unfold their leaves in the morning and fold them in the evening even when they were maintained in constant darkness.1 d'Ortous had discovered an innate regulatory mechanism that allowed the plants to anticipate when daylight would be expected to begin and to wane. It is now widely appreciated that since fluctuations of the environment occur in the 24 hours required by the earth to rotate once on its axis, it would be useful if organisms could be prepared suitably for these fluctuations. Indeed, circadian "clocks" have been identified in all eukaryocytic cells and even in some prokaryocytes.2 It has been suggested that circadian clocks were present in the earth's earliest life forms. The uniform presence of circadian rhythmicity suggests that the ability to anticipate changes in the environment and to prepare for them provides an evolutionary advantage, otherwise it would probably not have persisted.All mammals studied to date have developed 2 major classes of circadian clocks. The first to be recognized, the central "master" clock, is controlled by light, converted in the retina into neural impulses that are transmitted via the retinohypothalamic tract to the suprachiasmatic nucleus within the hypothalamus. This clock is responsible for circadian variations in the activity of the autonomic nervous system, resulting in changes in physiological parameters, including vascular resistance, arterial pressure, cardiac output, and heart rate as well as in the secretion of a variety of hormones, including cortisol and catecholamines.3The master clock also exerts some control on the second, and more recently discovered peripheral circadian clocks, which have been found in every type of mammalian cell studied thus far.2 However, these clocks can and do also function independently. Indeed, it is likely that it was these peripheral innate clocks that were responsible for the folding and unfolding of plant leaves described by d'Ortous. Most studies of these clocks have been carried out in the fungus Neurospora, in Drosophila and in a variety of rodents, but they have also been found in human cardiac tissue.4 These peripheral circadian clocks are controlled by so-called "CLOCK" genes that have been found to control approximately 10% of all genes expressed in the mouse heart, which exhibit circadian rhythmicity.5 This results in cyclic variations in mRNA and protein synthesis and thereby influence cardiac contractile function as well as oxidative and nonoxidative metabolism of carbohydrates and lipids. For example, the increase in the capacity to metabolize carbohydrates before awakening prepares the heart for the expected increased activity.Innate circadian variations in gene expression have been observed not only in cells obtained from intact hearts but also from cardiomyocytes studied in cell culture.2 The latter observations prove that they are truly innate, and although they may be influenced by the master clock in the intact organism, they are certainly capable of autonomous function. Cardiomyocyte-specific circadian clock mutant (CCM) mice, in which the circadian clock has been selectively disrupted, have provided important information on the function of these genes.6In 1985, in an analysis of the Multicenter Analysis of the Limitations of Infarct Size, Muller et al7 observed a marked circadian periodicity in the time of onset of the clinical manifestations of acute myocardial infarction, with a peak incidence between 6 am and noon. This increased morning incidence has been confirmed repeatedly in individual populations and in a meta-analysis of more than 60 000 patients.8 We observed that it was abolished in patients receiving β-blockers, suggesting that it is related to adrenergic activity,7 whereas Ridker et al9 showed that it was abolished by aspirin, pointing to an involvement of activated platelets in the process. We also found an increased incidence during early morning hours in unstable angina,10 which also has been reported by others for sudden death,11 stroke, ventricular arrhythmias, cardiogenic shock, aortic aneurysm rupture, stent thrombosis,12 and transient myocardial ischemia. Obviously, something is going on during these morning hours. It could be related to the morning increases in adrenergic activity13 as well as to circadian variation in thrombogenicity, such as a reduction of fibrinolytic activity. Indeed, in recent studies, Takeda et al14 have shown that the thrombomodulin gene, a clock-controlled gene, is responsible for circadian oscillation of thrombomodulin mRNA and protein. Other studies have shown that the CLOCK genes regulate the expression of both plasminogen activator inhibitor-1 as well as the morning increase of platelet aggregability.15 Thus, temporal changes in thrombogenicity can help to explain the circadian variation of the onset of cardiovascular events.In this issue of Circulation Research, Reiter et al16 describe circadian variation of another important component of acute coronary events, infarct size. They report that in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention, infarct size peaked at 1 am. This is about 8 hours earlier than the reported 6 am to noon peak of the onset of infarction.7,8 Because the area of myocardium at risk and the ischemic time (the interval between the onset of pain and the first inflation of the angioplasty balloon) in the study by Reiter et al16 did not vary during the 24-hour cycle, the observed circadian variation in infarct size probably is related to differences in reperfusion injury; hence, reperfusion injury was greatest at 1 am. Because there is increasing evidence that reperfusion injury results from opening of the permeability transition pore of the inner mitochondrial membrane, resulting in mitochondrial damage and thereby myocyte death,17 it could be hypothesized that in some manner, not yet determined, there is circadian fluctuation of the opening of this pore.These results by Reiter et al16 build on and add to previous preclinical and clinical observations. Durgan et al18 recently reported in mice that there was a >3-fold increase in infarct size when infarction/reperfusion was carried out at the sleep-wake transition than at the wake-to-sleep transition. They also provided evidence that the diurnal variation of 2 kinases, Akt and glycogen synthase kinase 3, may explain the differences in infarct size after ischemia/reperfusion. This circadian difference in reperfusion injury was not observed in CMM mice.The findings of Reiter et al are also consonant with 3 sets of observations on patients with acute myocardial infarction. Mukamal et al19 reported that the highest peak creatine kinase levels occurred in patients with myocardial infarction whose symptoms commenced between midnight and 6 am, and the highest incidence of heart failure was seen in patients whose symptoms began around midnight. In patients with acute ST-segment elevation myocardial infarction, Suarez-Barrientes20 showed that maximum infarct size estimated by biomarker release, depression of left ventricular ejection fraction, and the incidence of clinical heart failure were all greater in patients whose infarcts occurred between 6 am and noon. Arroyo Ucar et al21 reported that infarct sizes were larger in patients with ST-segment elevation myocardial infarction whose symptoms began between midnight and noon than those occurring between noon and midnight.Reiter et al should be commended for conducting this challenging translational research. Given the previous robust preclinical observations described by Durgan et al,18 and the above-mentioned clinical observations, Reiter et al's observations of circadian variation of infarct size in patients with acute myocardial infarction who are treated with reperfusion represent a useful independent confirmation.In many hospitals, patients whose infarcts develop between midnight and 6 am have longer prehospital delays and longer door-to-balloon times, with worse clinical outcomes,22 than those whose infarcts occur during daytime hours.23 When these procedural challenges are taken together with the increase in infarct size and greater myocardial damage in infarcts that begin at night, it becomes especially important for hospitals and their cardiologists to ensure that the quality of care that is rendered to patients with acute myocardial infarction does not also exhibit circadian variability.FootnotesThe opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.Correspondence to Eugene Braunwald, MD, TIMI Study Group, 350 Longwood Ave, Boston, MA 02115. E-mail [email protected]orgReferences1. Edery I. Circadian rhythms in a nutshell. Physiol Genom. 2000; 3: 59– 74 .CrossrefMedlineGoogle Scholar2. Durgan DJ, Young ME. The cardiomyocyte circadian clock: emerging roles in health and disease. Circ Res. 2010; 106: 647– 658.LinkGoogle Scholar3. Schefer FAJL, Ter Horst GJ, van der Vliet J, Bulis RM. Physiological and anatomic evidence for regulation of the heart by suprachiasmatic nucleus in rats. Am J Physiol Heart Circ Physiol. 2001; 280: H1391– H1399.CrossrefMedlineGoogle Scholar4. Leibsteder V, Humpeier S, Svoboda M, Schmid D, Thalhammer T, Zuckermann A, Marktl W, Ekmekcioglu C. Clock genes display rhythmic expression in human hearts. Chronobiol Int. 2009; 26: 621– 636.CrossrefMedlineGoogle Scholar5. Storch KF, Lipan O, Leykin I, Viswanathan N, Davis FC, Wong WH, Weitz CJ. Extensive and divergent circadian gene expression in liver and heart. Nature. 2002; 417: 78– 83.CrossrefMedlineGoogle Scholar6. Bray MS, Shaw CA, Moore MWS, Garcia RAP, Zanquetta MM, Durgan DJ, Jeong WJ, Tsai J-Y, Bugger H, Zhang D, Rohrwasser A, Rennison JH, Dyck JRB, Litwin SE, Hardin PE, Chow C-W, Chandler MP, Abel ED, Young ME. Disruption of the circadian clock within the cardiomyocyte influences myocardial contractile function, metabolism, and gene expression. Am J Physiol Heart Circ Physiol. 2008; 294: H1036– H1047.CrossrefMedlineGoogle Scholar7. Muller JE, Stone PH, Turi ZG, Rutherford JD, Czeisler CA, Parker C, Poole WK, Roberts R, Robertson T, Sobel BE, Willerson JT, Braunwald E, the MILIS Study Group. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med. 1985; 313: 1315– 1322.CrossrefMedlineGoogle Scholar8. Cohen MC, Rohtla KM, Lavery CE, Muller JE, Mittleman MA. Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am J Cardiol. 1997; 79: 1512– 1516.CrossrefMedlineGoogle Scholar9. Ridker PM, Manson JE, Buring JE, Muller JE, Hennekens CH. Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians. Circulation. 1990; 82: 897– 902.LinkGoogle Scholar10. Cannon CP, McCabe CH, Stone PH, Schactman M, Thompson B, Theroux P, Gibson RS, Feldman T, Kleiman NS, Tofler GH, Muller JE, Chaitman BR, Braunwald E. Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI II Registry and TIMI IIIB). Am J Cardiol. 1997; 79: 253– 258.CrossrefMedlineGoogle Scholar11. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 1989; 79: 733– 743.LinkGoogle Scholar12. Mahmoud KD, Lennon RJ, Ting HH, Rihal CS, Holmes DR. Circadian variation in coronary stent thrombosis. J Am Coll Cardiol: Cardiovasc Interv. 2011; 4: 183– 190.CrossrefGoogle Scholar13. Panza JA, Epstein SE, Quyyumi AA. Circadian variation in vascular tone and its relation to α-sympathetic vasoconstrictor activity. N Engl J Med. 1991; 325: 986– 990.CrossrefMedlineGoogle Scholar14. Takeda N, Maemura K, Horie S, Oishi K, Imai Y, Harada T, Saito T, Shiga T, Amiya E, Manabe I, Ishida N, Nagai . Thrombomodulin is a clock-controlled gene in vascular endothelial cells. J Biol Chem. 2007; 282: 32561– 32567.CrossrefMedlineGoogle Scholar15. Ohkura N, Oishi K, Sudo T, Hayashi H, Shikata K, Ishida N, Matsuda J, Horie S. CLOCK regulates circadian platelet activity. Thromb Res. 2009; 123: 523– 527.CrossrefMedlineGoogle Scholar16. Reiter R, Swingen C, Moore L, Henry TD, Traverse JH. Circadian dependence of infarct size and left-ventricular function following ST-elevation myocardial infarction. Circ Res. 2012; 110: 105– 110.LinkGoogle Scholar17. Hausenoy DJ, Yellon DM, Mani-Babu S, Duchen MR. Preconditioning protects by inhibiting the mitochondrial permeability transition. Am J Physiol Heart Circ Physiol. 2004; 287: H841– H849.CrossrefMedlineGoogle Scholar18. Durgan DJ, Pulinilkunnil T, Villegas-Montoya C, Garvey ME, Frangogiannis NG, Michael LH, Chow CW, Dyck JRB, Young ME. Ischemia/reperfusion tolerance is time-of-day-dependent. Circ Res. 2010; 106: 546– 550.LinkGoogle Scholar19. Mukamal KJ, Muller JE, Maclure M, Sherwood JB, Mittleman MA. Increased risk of congestive heart failure among infarctions with nighttime onset. Am Heart J. 2000; 140: 438– 442.CrossrefMedlineGoogle Scholar20. Suárez-Barrientos A, López-Romero P, Vivas D, Castro-Ferreira F, Nunez-Gil I, Franco E, Ruiz-Mateos B, Garcia Rubira JC, Fernandez-Ortiz A, Macaya C, Ibanez B. Circadian variations of infarct size in acute myocardial infarction. Heart. 2011; 97: 970– 976.CrossrefMedlineGoogle Scholar21. Arroyo Ucar E, Dominguez-Rodriguez A, Abreu-Gonzalez P. Influence of diurnal variation in the size of acute myocardial infarction. Med Intensiva. September5, 2011 [Epub ahead of print]. Google Scholar22. de Luca G, Suryapranata H, Ottervanger JP, van't Hoff AWJ, Hoorntje JCA, Gosselink ATM, Dambrink J-HE, Zijlstra F, de Boer M-J. Circadian variation in myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. Am Heart J. 2005; 150: 1185– 1189.CrossrefMedlineGoogle Scholar23. Holmes DR, Aguirre FV, Aplin R, Lennon RJ, Neestler DM, Bell MR, Rihal CS, Ting HH. Circadian rhythms in patients with ST-elevation myocardial infarction. Circ Cardiovasc Qual Outcomes. 2010; 3: 382– 389.LinkGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Oyama Y, Walker L and Eckle T (2021) Targeting circadian PER2 as therapy in myocardial ischemia and reperfusion injury, Chronobiology International, 10.1080/07420528.2021.1928160, 38:9, (1262-1273), Online publication date: 2-Sep-2021. Bartman C and Eckle T Circadian-Hypoxia Link and its Potential for Treatment of Cardiovascular Disease, Current Pharmaceutical Design, 10.2174/1381612825666190516081612, 25:10, (1075-1090) (2018) 循環器疾患の時間治療, Journal of JCS Cardiologists, 10.1253/jjcsc.26.0_11, 26:0, (11-18), . Brainard J, Gobel M, Scott B, Koeppen M and Eckle T (2015) Health Implications of Disrupted Circadian Rhythms and the Potential for Daylight as Therapy, Anesthesiology, 10.1097/ALN.0000000000000596, 122:5, (1170-1175), Online publication date: 1-May-2015. Brainard J, Gobel M, Bartels K, Scott B, Koeppen M and Eckle T (2014) Circadian Rhythms in Anesthesia and Critical Care Medicine, Seminars in Cardiothoracic and Vascular Anesthesia, 10.1177/1089253214553066, 19:1, (49-60), Online publication date: 1-Mar-2015. Bonney S, Hughes K, Harter P, Mittelbronn M, Walker L and Eckle T (2013) Cardiac Period 2 in myocardial ischemia: Clinical implications of a light dependent protein, The International Journal of Biochemistry & Cell Biology, 10.1016/j.biocel.2012.12.022, 45:3, (667-671), Online publication date: 1-Mar-2013. Oyama Y, Shuff S, Davizon-Castillo P, Clendenen N, Eckle T and Bartell P (2020) Intense light as anticoagulant therapy in humans, PLOS ONE, 10.1371/journal.pone.0244792, 15:12, (e0244792) January 6, 2012Vol 110, Issue 1 Advertisement Article InformationMetrics © 2012 American Heart Association, Inc.https://doi.org/10.1161/CIRCRESAHA.111.260265PMID: 22223205 Originally publishedJanuary 6, 2012 Keywordsmyocardial infarctionreperfusioncircadian rhythmPDF download Advertisement SubjectsAnimal Models of Human DiseaseGene Expression and RegulationMyocardial InfarctionStentThrombosis
Referência(s)